Hypertension Diagnostics Inc
Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marke… Read more
Market Cap & Net Worth: Hypertension Diagnostics Inc (HDII)
Hypertension Diagnostics Inc (PINK:HDII) has a market capitalization of $0.96 ($0.96) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51463 globally and #16208 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hypertension Diagnostics Inc's stock price $0.00 by its total outstanding shares 9643 (9.64K).
Hypertension Diagnostics Inc Market Cap History: 2015 to 2025
Hypertension Diagnostics Inc's market capitalization history from 2015 to 2025. Data shows change from $16.39 to $0.96 (-32.34% CAGR).
Hypertension Diagnostics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hypertension Diagnostics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Hypertension Diagnostics Inc's market cap is 0.00 times its annual revenue
0.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Hypertension Diagnostics Inc's market cap is 0.00 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.93 | $3.57 Million | -$622.00K | 0.00x | N/A |
| 2017 | $19.29 | $3.68 Million | -$368.61K | 0.00x | N/A |
| 2019 | $151.40 | $3.79 Million | $3.29 Million | 0.00x | 0.00x |
Competitor Companies of HDII by Market Capitalization
Companies near Hypertension Diagnostics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Hypertension Diagnostics Inc by market ranking:
- CLUS (PINK:CLUS): Ranked #1958 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8543 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8998 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10627 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1958 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8543 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8998 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30900.00 |
| #10627 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Hypertension Diagnostics Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Hypertension Diagnostics Inc's market cap moved from $16.39 to $ 0.96, with a yearly change of -32.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $0.96 | 0.00% |
| 2024 | $0.96 | -90.00% |
| 2023 | $9.64 | -58.33% |
| 2022 | $23.14 | -68.83% |
| 2021 | $74.25 | -56.00% |
| 2020 | $168.75 | +11.46% |
| 2019 | $151.40 | +1107.69% |
| 2018 | $12.54 | -35.00% |
| 2017 | $19.29 | -33.33% |
| 2016 | $28.93 | +76.47% |
| 2015 | $16.39 | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Hypertension Diagnostics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $0.96 USD |
| MoneyControl | $0.96 USD |
| MarketWatch | $0.96 USD |
| marketcap.company | $0.96 USD |
| Reuters | $0.96 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.